Stephen David Penrose

Title: Stephen David Penrose: Innovator in P2X3 Inhibitors

Introduction

Stephen David Penrose is a notable inventor based in Parma, Italy. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that target specific receptors in the body.

Latest Patents

Penrose holds a patent for "Pyridopyrimidines derivatives as P2X3 inhibitors." This invention relates to compounds that inhibit the P2X purinoceptor 3, which are particularly useful in treating various respiratory diseases. The patent outlines methods for preparing these compounds, their pharmaceutical compositions, and their therapeutic applications. The compounds may be beneficial in treating disorders such as cough, asthma, idiopathic pulmonary fibrosis (IPF), and chronic obstructive pulmonary disease (COPD). He has 1 patent to his name.

Career Highlights

Stephen David Penrose is associated with Chiesi Farmaceutici S.p.a., a company known for its innovative pharmaceutical solutions. His work focuses on developing new therapeutic agents that can improve patient outcomes in respiratory health.

Collaborations

Throughout his career, Penrose has collaborated with talented professionals, including Roberta Lanaro and Matteo Biagetti. These collaborations have contributed to the advancement of research and development in the pharmaceutical industry.

Conclusion

Stephen David Penrose is a distinguished inventor whose work in P2X3 inhibitors has the potential to impact the treatment of respiratory diseases significantly. His contributions to the field exemplify the importance of innovation in healthcare.